Coronado Biosciences, Inc., has formed a new subsidiary company, DiaVax Biosciences, to develop novel immunotherapies for the prevention and treatment of cytomegalovirus , a common virus that affects people of all ages. According to the U.S. Centers for Disease Control and Prevention , while CMV is typically asymptomatic in healthy individuals, it can cause serious, often life-threatening disease in those with weakened or uneducated immune systems .
http://ift.tt/1GjOB3s
http://ift.tt/1GjOB3s
No comments:
Post a Comment